Omeros (OMER) Stock Price, Quote, News & History | Benzinga

SPY762.36−1.22%QQQ709.38−2.56%BTC/USD81,667.00−0.57%DIA518.53−0.49%GLD381.25−0.38%TLT80.05+0.10%

Omeros Corp (OMER) Stock Price, Quote, News & History

OMERNASDAQ

Trade with Public

Trade with Public

$16.20

-2.59-13.78%

Last update: Oct 16, 5:32 PM

$16.52

-2.27-12.08%

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

$17.94

Close

$16.20

Volume / Avg.

3.96M / 1.71M

Day Range

$16.52 - $16.52

52 Wk Range

4.06 - 21.24

Market Cap

$1.33B

P/E Ratio

11.39

Dividend Yield

-

Exchange

NASDAQ

RSI

35

Short Interest

16.3%

Days to Cover

6.95

Recent Omeros Corporation News

Truist Financial, Regions Financial And Other Big Stocks Moving Lower In Friday’s Pre-Market Session

U.S. stock futures mixed; Truist slips after mixed results, while Telkom Indonesia, Loma Negra, Omeros and others fall premarket.

Avi Kapoor

Omeros Stock Sinks on Negative EU Opinion for Narsoplimab, Compassionate-Use Program Ends

Omeros shares are trading lower Friday after the company announced that the EMA’s CHMP upheld its negative opinion on narsoplimab for TA-TMA.

Dylan Berman

This 3M Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Friday

Analysts upgraded First Financial, 3M, Synopsys, Humana and Stem, raising targets for four while maintaining Stem’s $7 target.

Avi Kapoor

Omeros Transplant Drug Could Be Bigger than Expected, Says Analyst

Cantor upgrades Omeros to Overweight with a $22 price forecast following strong Yartemlea sales and Medicare reimbursement momentum.

Vandana Singh

On Holding, Viking Therapeutics, Shopify And Other Big Stocks Moving Higher On Tuesday

U.S. stocks rose, led by On Holding's 13% surge after strong guidance and a $1B buyback; Viking Therapeutics and others also gained.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-68.67M

Investing Cash Flow (TTM)

136.82M

Financing Cash Flow (TTM)

-68.06M

Free Cash Flow (TTM)

-68.73M

Capital Expenditure (TTM)

-56.00K

Net Change in Cash (TTM)

84.00K

Analyst Trends and Forecast

1

Apr

1

May

2

Jun

1

Sep

1

Oct

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.3

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$1.37B

PE Ratio (TTM)

11.39

PE Ratio (FWD)

78.13

PEG Ratio (TTM)

-

PS Ratio (TTM)

38.78

PB Ratio (TTM)

-

Earnings Yield % (TTM)

8.78%

Earnings Yield % (FWD)

1.28%

EV / EBITDA (TTM)

146.26

Price / EBITDA (TTM)

159.38

Price / Free Cash Flow (TTM)

-

Book Value / Share

-$0.71

Company Debt

Total Debt

$128.51M

LT Debt

$97.25M

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-$108.60M

Total Cash

$1.99M

Debt to Equity

-

Issuance of Debt (TTM)

-$108.60M

Repayment of Debt (TTM)

-$108.60M